Status:
COMPLETED
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
University of Milan
Pavia IRCCS Mondino di Pavia
Conditions:
Fibromyalgia
Chronic Migraine, Headache
Eligibility:
FEMALE
18-65 years
Brief Summary
Chronic pain (CP) is a substantial healthcare challenge with considerable economic costs. Recently, the term Nociplastic Pain (NP) has been introduced as a third descriptor of mechanisms related to CP...
Detailed Description
Chronic pain (CP), defined as pain lasting more than 3 months, is a substantial healthcare challenge. Prevalence rates of CP are between 11% and 40% (Dahlhamer et al., 2018; Fayaz et al., 2016). CP pr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age range 18-65 years
- education \> 5 years
- diagnosis of FM according to Wolfe, 2016
- diagnosis of CM according to Olesen, 2017
- diagnosis of VU according to Bornstein et al., 2016
- Exclusion criteria
- severe psychiatric disorders and/or cognitive impairment
- difficulties in comprehension/expression in Italian
- history of other chronic pain disorder(s)
- history of other neurological disorders besides migraine
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
1006 Patients enrolled
Trial Details
Trial ID
NCT06138171
Start Date
October 1 2023
End Date
December 1 2024
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome, Department of Dynamic and Clinical Psychology and Health Studies
Rome, Italy, 00100